Galmed Pharmaceuticals (GLMD) Institutional Ownership

→ Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad)

Free GLMD Stock Alerts

$0.35

0.00 (0.00%)

(As of 06/11/2024 ET)

Compare

Current Institutional Ownership Percentage: 76.14%
Number of Institutional Buyers (last 12 months): 0

Number of Institutional Sellers (last 12 months): 2
Total Institutional Outflows (last 12 months): $3.73M

Get GLMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Galmed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GLMD Institutional Buying and Selling by Quarter

Ad Weiss Ratings

Protect Your Bank Account Before It’s Too Late

For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …

Stop right now and do these 3 things to protect yourself

Galmed Pharmaceuticals Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2024	CVI Holdings LLC	74,665	$25K	0.0%	-72.3%	1.479%
8/15/2023	BVF Inc. IL	89,853	$261K	0.0%	-93.3%	5.348%
5/16/2023	BVF Inc. IL	1,347,755	$575K	0.0%	-22.5%	5.348%
7/18/2022	Western Wealth Management LLC	59,074	$38K	0.0%	N/A	0.235%
2/8/2022	Raymond James & Associates	203,540	$370K	0.0%	-11.4%	0.811%
2/7/2022	Ibex Investors LLC	874,144	$1.59M	0.5%	-26.7%	3.485%
Get the Latest News and Ratings for GLMD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
11/16/2021	Squarepoint Ops LLC	25,404	$71K	0.0%	-22.2%	0.101%
11/16/2021	Toroso Investments LLC	24,657	$69K	0.0%	N/A	0.098%
11/5/2021	Ibex Investors LLC	1,193,100	$3.33M	0.7%	-2.3%	4.756%
11/2/2021	Raymond James Financial Services Advisors Inc.	21,304	$59K	0.0%	+27.2%	0.085%
11/2/2021	Raymond James & Associates	229,640	$641K	0.0%	+10.5%	0.915%
8/16/2021	Squarepoint Ops LLC	32,634	$99K	0.0%	-40.5%	0.130%
8/16/2021	Nantahala Capital Management LLC	944,631	$2.87M	0.1%	-22.2%	3.766%
8/16/2021	Ibex Investors LLC	1,220,794	$3.71M	1.3%	-19.9%	4.867%
8/5/2021	Ibex Investors LLC	1,220,794	$3.71M	1.3%	-19.9%	4.868%
7/31/2021	Brave Asset Management Inc.	11,470	$35K	0.0%	N/A	0.046%
5/19/2021	Squarepoint Ops LLC	54,884	$188K	0.0%	+161.2%	0.219%
5/17/2021	Goldman Sachs Group Inc.	26,419	$91K	0.0%	N/A	0.105%
5/14/2021	Nantahala Capital Management LLC	1,213,540	$4.16M	0.1%	-37.0%	4.838%
5/13/2021	Renaissance Technologies LLC	60,700	$208K	0.0%	-47.6%	0.242%
3/26/2021	Susquehanna International Group LLP	10,483	$33K	0.0%	N/A	0.042%
2/16/2021	Squarepoint Ops LLC	21,010	$65K	0.0%	-12.5%	0.100%
2/16/2021	Baker BROS. Advisors LP	184,927	$575K	0.0%	-10.0%	0.876%
2/10/2021	Renaissance Technologies LLC	115,800	$360K	0.0%	+238.2%	0.548%
2/3/2021	Ibex Investors LLC	1,525,000	$4.74M	1.9%	+0.7%	7.223%
11/16/2020	Squarepoint Ops LLC	24,024	$85K	0.0%	N/A	0.114%
11/13/2020	Morgan Stanley	130,165	$459K	0.0%	+17.6%	0.617%
11/12/2020	Voss Capital LLC	125,000	$443K	0.3%	-6.6%	0.592%
11/10/2020	Phoenix Holdings Ltd.	145,865	$480K	0.0%	+8.5%	0.691%
11/9/2020	P.A.W. Capital Corp	200,000	$706K	0.8%	+100.0%	0.947%
11/4/2020	Raymond James & Associates	228,569	$807K	0.0%	-57.2%	1.083%
11/3/2020	Ibex Investors LLC	1,515,000	$5.35M	2.8%	+53.8%	7.176%
10/20/2020	Wedbush Securities Inc.	13,003	$46K	0.0%	N/A	0.062%
8/14/2020	Nantahala Capital Management LLC	2,072,745	$9.91M	0.3%	+59.0%	9.817%
8/14/2020	BVF Inc. IL	1,799,694	$8.60M	0.5%	-1.8%	8.524%
8/12/2020	Ibex Investors LLC	985,000	$4.71M	2.2%	+2.1%	4.665%
7/28/2020	Raymond James & Associates	534,609	$2.56M	0.0%	+55.3%	2.532%
5/20/2020	Phoenix Holdings Ltd.	75,383	$253K	0.0%	+312.9%	0.357%
5/18/2020	Vivo Capital LLC	860,103	$2.98M	0.3%	N/A	4.069%
5/15/2020	Squarepoint Ops LLC	34,350	$119K	0.0%	+238.9%	0.162%
Top 5 Tech Stocks to Buy for 2024 (Ad) The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024",
5/15/2020	Voss Capital LLC	159,454	$319K	0.4%	+5.9%	0.754%
5/15/2020	Morgan Stanley	77,552	$269K	0.0%	+24.6%	0.367%
5/15/2020	Two Sigma Securities LLC	16,330	$57K	0.0%	N/A	0.077%
5/14/2020	Ibex Investors LLC	965,000	$3.34M	3.4%	+1.0%	4.565%
5/14/2020	ETF Managers Group LLC	41,548	$143K	0.0%	+9.8%	0.197%

(Data available from 1/1/2016 forward)

GLMD Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of GLMD shares?: During the previous two years, the following institutional investors and hedge funds held shares of Galmed Pharmaceuticals shares: BVF Inc. IL ($261K), and Western Wealth Management LLC ($38K), CVI Holdings LLC ($25K).Learn more on GLMD's institutional investors.
What percentage of Galmed Pharmaceuticals stock is owned by institutional investors?: 76.14% of Galmed Pharmaceuticals stock is owned by institutional investors. Learn more on GLMD's institutional investor holdings.
Which institutional investors have been buying Galmed Pharmaceuticals stock?: The following institutional investors have purchased Galmed Pharmaceuticals stock in the last 24 months: Western Wealth Management LLC ($59.07K).

How much institutional buying is happening at Galmed Pharmaceuticals?: Institutional investors have bought a total of 59,074 shares in the last 24 months. This purchase volume represents approximately $575.97K in transactions.
Which Galmed Pharmaceuticals major shareholders have been selling company stock?: The following institutional investors have sold Galmed Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($1.65M), and CVI Holdings LLC ($194.57K).
How much institutional selling is happening at Galmed Pharmaceuticals?: Institutional investors have sold a total of 1,844,390 shares in the last 24 months. This volume of shares sold represents approximately $6.24M in transactions.